Digital Twin
Dynamic models of human biology powered by AI, multi-omics, and systems biology.
A New Systems Paradigm for Drug Discovery
By representing the human body as a dynamic, interconnected system—spanning molecular processes, organs, and microbial ecosystems Digital Twin enables in silicoevaluation of disease mechanisms, therapeutic strategies, and safety risks.
What Digital Twin Enables
Rather than producing abstract predictions, Digital Twin is built to answer concrete, decision-relevant questions through mechanistic simulation of system behaviour.
Mechanistic Insights
How can we formally represent health and disease as dynamic, system-level biological states?
Toxicity Assessment
What are the potential safety risks of a proposed intervention, and how might these vary?
Efficacy Projections
How do biological systems respond to specific interventions, and which system-level effects emerge before clinical observation?
Core Foundations
Three fundamental principles that power Digital Twin's approach to modelling human biology and disease.
Dynamic Models of Human Biology
Digital Twin models health and disease as trajectories through biological state space. Multi-omics measurements, microbiome profiles, and clinical data are assimilated to estimate how system state changes over time and under intervention.
Mechanistic Foundations with Predictive Consequences
Biological processes are represented explicitly through causal networks that connect genes, proteins, metabolites, organs, and microbial functions. This structure ensures predictions remain interpretable and biologically consistent.
Accounting for Host–Microbiome Effects
Digital Twin explicitly incorporates interactions between host biology and microbial ecosystems, modelling microbial metabolism and ecological dynamics alongside host processes to anticipate variability in drug exposure and metabolic response.
Impact Across Medicine and Drug Development
Better-informed decisions, grounded in system-level biology rather than isolated signals.
Personalised Medicine
Digital Twin functions as an evolving computational counterpart of the patient or cohort. Interventions can be evaluated virtually, refined as new data arrive, and adapted over time.
Drug Discovery & Development
Digital Twin serves as a mechanistic in-silico testbed for therapeutic hypotheses. Drug targets and interventions can be evaluated within a system-level biological context, enabling early assessment of efficacy, safety, and population-specific responses.
Built to Scale with Biology
Digital Twin is designed as a living modelling framework. Its architecture allows additional physiological systems, data modalities, and feedback mechanisms to be incorporated over time, expanding biological coverage without sacrificing coherence. By unifying systems biology, multi-omics integration, and AI-driven inference within a dynamic, interpretable framework, Trustlife's Digital Twin provides a foundation for translating biological complexity into practical insight—at scale.